Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors |
| |
Authors: | Pinar Asli Yurdakul Pinar Yildiz Ilkay Temiz-Arpaci Ozlem Acan N Leyla Aki-Sener Esin Yalcin Ismail |
| |
Institution: | Department of Biochemistry, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey. |
| |
Abstract: | Our previously synthesized 37 compounds, which are 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole, and oxazolo(4,5-b)pyridine derivatives, were tested for their eukaryotic DNA topoisomerase II inhibitory activity in cell free system and 28 were found to inhibit the topoisomerase II at an initial concentration of 100 microg/ml. After further testing at a lower range of concentrations, 12 derivatives, which were considered as positive topoisomerase inhibitors, exhibited IC50 values between 11.4 and 46.8 microM. Etoposide was used as the standard reference drug to compare the inhibitor activity. Among these compounds, 2-phenoxymethylbenzothiazole (3f), 6-nitro-2-(2-methoxyphenyl)benzoxazole (1a), 5-methylcarboxylate-2-phenylthiomethylbenzimidazole (3c), and 6-methyl-2-(2-nitrophenyl)benzoxazole (1c) were found to be more active than the reference drug etoposide. Present results point out that, besides the very well-known bi- and ter-benzimidazoles, compounds with single bicycle fused ring systems in their structure such as benzimidazole, benzoxazole, benzothiazole, and/or oxazolopyridine derivatives also exhibit significant topoisomerase II inhibitory activity. |
| |
Keywords: | Topoisomerase II Inhibitory activity Benzoxazoles Benzimidazoles Benzothiazoles Oxazolopyridines |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|